Parker Waichman LLP

May 17, 2024

JASON S. GOLDSTEIN OF PARKER WAICHMAN LLP NAMED TO PLAINTIFFS' STEERING COMMITTEE IN NATIONAL GLUGAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION

Oct 18, 2019

Parker Waichman LLP is Reviewing Talcum Powder Mesothelioma Cancer Cases

Jul 26, 2019

Parker Waichman LLP initiates lawsuits of behalf of more than 500 disabled veterans who sustained permanent hearing loss and/or tinnitus after using defective 3M Dual-Ended Combat Arms(TM) Earplugs.

May 14, 2018

Parker Waichman LLP is Investigating Potential Neurovascular Stent Claims Following Recent FDA Safety Alert

Jan 02, 2018

Lawsuits Filed Against J&J Related to its Drug Invokana

Oct 05, 2017

Parker Waichman LLP Comments: DePuy Synthes Attune Knee Device Lawsuits Mounting

Oct 03, 2017

Parker Waichman LLP Comments On Study: DePuy Synthes Attune Knee Devices Failing Prematurely

Sep 26, 2017

Millions of Consumers May Have Been Impacted by Equifax Breach, says Parker Waichman

Sep 15, 2017

Medtronic Recalls MiniMed Infusion Sets Over Blockage Issues

Jul 21, 2017

Rheumatoid Arthritis Drug, Actemra, Tied to Significant Side Effects